| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-07 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
6e-06 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
5e-05 |
| mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
0.0001 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.0003 |